Literature DB >> 20009392

The influence of Helicobacter pylori eradication on leptin, soluble CD40 ligand, oxidative stress and body composition in patients with peptic ulcer disease.

Levent Kebapcilar1, Ismail Sari, Ali Haydar Renkal, Ahmet Alacacioglu, Arif Yuksel, Enver Ilhan, Bulent Alkan, Diydem Yuksel, Didem L Kozaci, Necati Gunay.   

Abstract

OBJECTIVE: To determine the effect of Helicobacter pylori (H. pylori) eradication on blood levels of soluble CD40 ligand, leptin, oxidative stress and body composition in patients with dyspepsia infected with H. pylori.
METHODS: The infection of H. pylori was based on the presence of both (14)C urea breath test (UBT) and histology. Patients were given triple eradication therapy for 14 days and at 3 months after the treatment, (14)C UBT was reinstituted. Fasting glucose, leptin, body composition, soluble CD40 ligand, total oxidant status (TOS) were studied before and at 3 months after the treatment.
RESULTS: In 33 subjects, H. pylori infection was successfully eradicated. sCD40L, and TOS levels were significantly decreased after H. pylori eradication. The percentage of body fat and body fat mass significantly decreased whereas the fat free mass (FFM) increased after eradication. However, eradication of the organism yielded no differences in leptin levels.
CONCLUSION: These findings suggest that H. pylori eradication reduces the sCD40L and oxidative stress, fat mass with a significant increase in fat free mass. Thus, eradication of H. pylori infection not only improves ulcer healing, but may also reduce the presumed atherosclerosis risk.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20009392     DOI: 10.2169/internalmedicine.48.2562

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  7 in total

1.  Influence of Helicobacter pylori infection on metabolic parameters and body composition of dyslipidemic patients.

Authors:  Elena Moretti; Stefano Gonnelli; Mariastella Campagna; Ranuccio Nuti; Giulia Collodel; Natale Figura
Journal:  Intern Emerg Med       Date:  2014-01-14       Impact factor: 3.397

2.  Standard triple therapy in Helicobacter pylori eradication in Turkey: Systematic evaluation and meta-analysis of 10-year studies.

Authors:  Orhan Sezgin; Mehmet Kasım Aydın; Asena Ayça Özdemir; Arzu Emine Kanık
Journal:  Turk J Gastroenterol       Date:  2019-05       Impact factor: 1.852

3.  Helicobacter pylori seropositivity in diabetic patients is associated with microalbuminuria.

Authors:  Goh Eun Chung; Nam Ju Heo; Min Jung Park; Su Jin Chung; Hae Yeon Kang; Seung Joo Kang
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

Review 4.  Helicobacter pylori infection and circulating ghrelin levels - a systematic review.

Authors:  Chidi V Nweneka; Andrew M Prentice
Journal:  BMC Gastroenterol       Date:  2011-01-26       Impact factor: 3.067

Review 5.  Relationship Between Helicobacter pylori Infection and Arteriosclerosis.

Authors:  Yoshitaka Furuto; Mariko Kawamura; Jumpei Yamashita; Takahiro Yoshikawa; Akio Namikawa; Rei Isshiki; Hiroko Takahashi; Yuko Shibuya
Journal:  Int J Gen Med       Date:  2021-04-23

6.  Elderly women who received Helicobacter pylori-eradicating therapy have reduced risk of low skeletal muscle mass.

Authors:  Myong Ki Baeg; Myung-Gyu Choi; Sun-Hye Ko; Chul-Hyun Lim; Jin Su Kim; Yu Kyung Cho; Jae Myung Park; Young-Seok Cho; Bo-In Lee; In-Seok Lee
Journal:  Clin Interv Aging       Date:  2015-10-30       Impact factor: 4.458

Review 7.  Gut Microbiota: The Missing Link Between Helicobacter pylori Infection and Metabolic Disorders?

Authors:  Gracia M Martin-Nuñez; Isabel Cornejo-Pareja; Mercedes Clemente-Postigo; Francisco J Tinahones
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-17       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.